Bizcommunity on MSN
Lessons from Novo Nordisk’s Ozempic patent loss in Canada
Lately, it has become almost impossible to have a conversation about weight loss without the name semaglutide, more commonly known by its blockbuster brand, Ozempic, being mentioned.
You're currently following this author! Want to unfollow? Unsubscribe via the link in your email. Three people who lost weight sustainably after years of yo-yo dieting shared the most valuable lessons ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results